Pediatric dosing of antimicrobials: Difference between revisions

From IDWiki
(: added glycopeptides)
(: combined age and weight columns)
Line 6: Line 6:
! Drug
! Drug
! Indication
! Indication
! Age
! Age and weight
! Weight
! Dose
! Usual dose
|-
|-
| rowspan=2 | [[Penicillin]] G IV/IM
| rowspan=2 | [[Penicillin]] G IV/IM
| moderate to severe infections
| moderate to severe infections
|
| colspan=2 |
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
|-
|-
| meningitis
| meningitis
|
| colspan=2 |
| 400,000 U/kg/day split q4h (max 24 MU/day)
| 400,000 U/kg/day split q4h (max 24 MU/day)
|-
|-
| rowspan=6 | [[Penicillin]] VK PO
| rowspan=6 | [[Penicillin]] VK PO
| mild to moderate infections
| mild to moderate infections
|
| colspan=2 |
| 25-50 mg/kg/day split q8-12h
| 25-50 mg/kg/day split q8-12h
|-
|-
| rowspan=2 | rheumatic fever (treatment)
| rowspan=2 | rheumatic fever (treatment)
| rowspan=2 |
| ≤ 27 kg
| ≤ 27 kg
| 300 mg PO bid x10 days
| 300 mg PO bid x10 days
Line 34: Line 32:
| rheumatic fever (prophylaxis)
| rheumatic fever (prophylaxis)
| > 5 years
| > 5 years
|
| 300 mg PO bid
| 300 mg PO bid
|-
|-
| rowspan=2 | asplenia (prophylaxis)
| rowspan=2 | asplenia (prophylaxis)
| 6 months to 5 years
| 6 months to 5 years
| rowspan=2 |
| 150 mg PO bid
| 150 mg PO bid
|-
|-
Line 47: Line 43:
| [[Cloxacillin]] IV
| [[Cloxacillin]] IV
| methicillin-susceptible [[Staphylococcus aureus]]
| methicillin-susceptible [[Staphylococcus aureus]]
|
| colspan=2 |
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
|-
|-
| [[Cloxacillin]] PO
| [[Cloxacillin]] PO
| colspan=3 |
| colspan=2 |
| use [[cephalexin]] instead
| use [[cephalexin]] instead
|-
|-
Line 57: Line 53:
| rowspan=2 | usual dose
| rowspan=2 | usual dose
| neonates
| neonates
|
| 100-200 mg/kg/day split q6-8h
| 100-200 mg/kg/day split q6-8h
|-
|-
| infants and children
| infants and children
|
| 100-200 mg/kg/day split q6h (max 2 g/dose)
| 100-200 mg/kg/day split q6h (max 2 g/dose)
|-
|-
| rowspan=2 | meningitis
| rowspan=2 | meningitis
| neonates
| neonates
|
| 300 mg/kg/day split q6-8h
| 300 mg/kg/day split q6-8h
|-
|-
| infants and children
| infants and children
|
| 300-400 mg/kg/day split q4-6h (max 2 g/dose)
| 300-400 mg/kg/day split q4-6h (max 2 g/dose)
|-
|-
| rowspan=3 | [[Amoxicillin]] PO
| rowspan=3 | [[Amoxicillin]] PO
| usual dose
| usual dose
|
| colspan=2 |
| 40-50 mg/kg/day split q8h
| 40-50 mg/kg/day split q8h
|-
|-
| [[Streptococcus pneumoniae]]
| [[Streptococcus pneumoniae]]
|
| colspan=2 |
| 80-90 mg/kg/day split q8h
| 80-90 mg/kg/day split q8h
|-
|-
| [[Group A Streptococcus]] pharyngitis
| [[Group A Streptococcus]] pharyngitis
|
| colspan=2 |
| 50 mg/kg once daily x10 days (max 1 g/dose)
| 50 mg/kg once daily x10 days (max 1 g/dose)
|-
|-
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO
| usual dose
| usual dose
|
| colspan=2 |
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
|-
|-
| [[Streptococcus pneumoniae]]
| [[Streptococcus pneumoniae]]
|
| colspan=2 |
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
|-
|-
| rowspan=2 | [[Piperacillin-tazobactam]] IV
| rowspan=2 | [[Piperacillin-tazobactam]] IV
| usual dose
| usual dose
|
| colspan=2 |
| 240-300 mg/kg/day (pip component) split q6-8h
| 240-300 mg/kg/day (pip component) split q6-8h
|-
|-
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]]
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]]
|
| colspan=2 |
| 400 mg/kg/day split q6h
| 400 mg/kg/day split q6h
|}
|}
Line 109: Line 101:
! Drug
! Drug
! Indication
! Indication
! Age
! Age and weight
! Weight
! Dose
! Usual dose
|-
|-
! colspan=5 | First generation
! colspan=5 | First generation
Line 117: Line 108:
| [[Cefazolin]] IV/IM
| [[Cefazolin]] IV/IM
| usual dose
| usual dose
|
| colspan=2 |
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
|-
|-
| rowspan=2 | [[Cephalexin]] PO
| rowspan=2 | [[Cephalexin]] PO
| usual dose
| usual dose
|
| colspan=2 |
| 25-100 mg/kg/day split qid
| 25-100 mg/kg/day split qid
|-
|-
| [[osteomyelitis]] (oral step-down)
| [[osteomyelitis]] (oral step-down)
|
| colspan=2 |
| 100-150 mg/kg/day split qid
| 100-150 mg/kg/day split qid
|-
|-
Line 133: Line 124:
| [[Cefuroxime]] IV/IM
| [[Cefuroxime]] IV/IM
| usual dose
| usual dose
|
| colspan=2 |
| 100-150 mg/kg/day split q8h (max 2 g/dose)
| 100-150 mg/kg/day split q8h (max 2 g/dose)
|-
|-
| [[Cefuroxime]] azetil PO
| [[Cefuroxime]] azetil PO
| colspan=3 |
| colspan=2 |
| poor bioavailability; not recommended
| poor bioavailability; not recommended
|-
|-
| [[Cefprozil]] PO
| [[Cefprozil]] PO
| usual dose
| usual dose
|
| colspan=2 |
| 15-30 mg/kg/day split bid (max 1 g/day)
| 15-30 mg/kg/day split bid (max 1 g/day)
|-
|-
Line 150: Line 141:
| rowspan=3 | usual dose
| rowspan=3 | usual dose
| 0-7 days
| 0-7 days
|
| 50 mg/kg/dose q8h
| 50 mg/kg/dose q8h
|-
|-
| >7 days
| >7 days
|
| 50 mg/kg/dose q8h
| 50 mg/kg/dose q8h
|-
|-
| infants and children
| infants and children
|
| 100-200 mg/kg/day split q6-8h (max 6 g/day)
| 100-200 mg/kg/day split q6-8h (max 6 g/day)
|-
|-
| rowspan=3 | [[meningitis]]
| rowspan=3 | [[meningitis]]
| 0-7 days
| 0-7 days
|
| 50 mg/kg/dose q8h
| 50 mg/kg/dose q8h
|-
|-
| >7 days
| >7 days
|
| 50 mg/kg/dose q6h
| 50 mg/kg/dose q6h
|-
|-
| infants and children
| infants and children
|
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
|-
|-
Line 177: Line 162:
| usual dose
| usual dose
| >1 month
| >1 month
|
| 50-75 mg/kg q24h (max 2 g/day)
| 50-75 mg/kg q24h (max 2 g/day)
|-
|-
| [[meningitis]]
| [[meningitis]]
| >1 month
| >1 month
|
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
|-
|-
| rowspan=2 | [[gonorrhea]]
| rowspan=2 | [[gonorrhea]]
| ≥9 years
| ≥9 years
|
| 250 mg IM once
| 250 mg IM once
|-
|-
| <9 years
| <9 years
|
| 50 mg/kg IM once (max 250 mg)
| 50 mg/kg IM once (max 250 mg)
|-
|-
| rowspan=2 | [[Ceftazidime]] IM/IV
| rowspan=2 | [[Ceftazidime]] IM/IV
| usual dose
| usual dose
|
| colspan=2 |
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
|-
|-
| [[meningitis]] or [[cystic fibrosis]]
| [[meningitis]] or [[cystic fibrosis]]
|
| colspan=2 |
| 200 mg/kg/day split q6-8h (max 6 g/day)
| 200 mg/kg/day split q6-8h (max 6 g/day)
|-
|-
| [[Cefixime]] PO
| [[Cefixime]] PO
| usual dose
| usual dose
|
| colspan=2 |
| 8 mg/kg/day split q12-24h (max 400 mg/day)
| 8 mg/kg/day split q12-24h (max 400 mg/day)
|}
|}
Line 214: Line 195:
! Drug
! Drug
! Indication
! Indication
! Age
! Age and weight
! Weight
! Dose
! Usual dose
|-
|-
| rowspan=2 | [[Meropenem]]
| rowspan=2 | [[Meropenem]]
| usual dose
| usual dose
|
| colspan=2 |
| 20 mg/kg/dose q8h (max 1 g/dose)
| 20 mg/kg/dose q8h (max 1 g/dose)
|-
|-
| [[meningitis]]
| [[meningitis]]
|
| colspan=2 |
| 40 mg/kg/dose q8h (max 2 g/dose)
| 40 mg/kg/dose q8h (max 2 g/dose)
|-
|-
Line 230: Line 210:
| rowspan=2 | usual dose
| rowspan=2 | usual dose
| 3 months to 12 years
| 3 months to 12 years
|
| 15 mg/kg/dose q12h (max 500 mg/dose)
| 15 mg/kg/dose q12h (max 500 mg/dose)
|-
|-
| ≥13 years
| ≥13 years
|
| 1 g daily
| 1 g daily
|}
|}
Line 243: Line 221:
! Drug
! Drug
! Indication
! Indication
! Age
! Age and weight
! Weight
! Usual dose
! Usual dose
|-
|-
| rowspan=2 | [[Vancomycin]] IV
| rowspan=2 | [[Vancomycin]] IV
| usual dose
| usual dose
|
| colspan=2 |
| 40-60 mg/kg/day split q6-12h (max 2+ g/day)
| 40-60 mg/kg/day split q6-12h (max 2+ g/day)
|-
|-
| [[meningitis]] or [[MRSA]]
| [[meningitis]] or [[MRSA]]
|
| colspan=2 |
| 60 mg/kg/day split q6-8h (max 4 g/day)
| 60 mg/kg/day split q6-8h (max 4 g/day)
|-
|-
| [[Vancomycin]] PO
| [[Vancomycin]] PO
| [[Clostridium difficile]]
| [[Clostridium difficile]]
|
| colspan=2 |
| 10 mg/kg/dose q6h (max 125 mg/dose)
| 10 mg/kg/dose q6h (max 125 mg/dose)
|}
|}

Revision as of 11:56, 18 November 2019

Antibiotics

Penicillins

Drug Indication Age and weight Dose
Penicillin G IV/IM moderate to severe infections 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day)
meningitis 400,000 U/kg/day split q4h (max 24 MU/day)
Penicillin VK PO mild to moderate infections 25-50 mg/kg/day split q8-12h
rheumatic fever (treatment) ≤ 27 kg 300 mg PO bid x10 days
> 27 kg 600 mg PO bid x 10 days
rheumatic fever (prophylaxis) > 5 years 300 mg PO bid
asplenia (prophylaxis) 6 months to 5 years 150 mg PO bid
> 5 years 300 mg PO bid
Cloxacillin IV methicillin-susceptible Staphylococcus aureus 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day)
Cloxacillin PO use cephalexin instead
Ampicillin IV usual dose neonates 100-200 mg/kg/day split q6-8h
infants and children 100-200 mg/kg/day split q6h (max 2 g/dose)
meningitis neonates 300 mg/kg/day split q6-8h
infants and children 300-400 mg/kg/day split q4-6h (max 2 g/dose)
Amoxicillin PO usual dose 40-50 mg/kg/day split q8h
Streptococcus pneumoniae 80-90 mg/kg/day split q8h
Group A Streptococcus pharyngitis 50 mg/kg once daily x10 days (max 1 g/dose)
Amoxicillin-clavulanic acid PO usual dose 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
Streptococcus pneumoniae 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose)
Piperacillin-tazobactam IV usual dose 240-300 mg/kg/day (pip component) split q6-8h
Pseudomonas aeruginosa or cystic fibrosis 400 mg/kg/day split q6h

Cephalosporins

Drug Indication Age and weight Dose
First generation
Cefazolin IV/IM usual dose 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
Cephalexin PO usual dose 25-100 mg/kg/day split qid
osteomyelitis (oral step-down) 100-150 mg/kg/day split qid
Second generation
Cefuroxime IV/IM usual dose 100-150 mg/kg/day split q8h (max 2 g/dose)
Cefuroxime azetil PO poor bioavailability; not recommended
Cefprozil PO usual dose 15-30 mg/kg/day split bid (max 1 g/day)
Third generation
Cefotaxime IV/IM usual dose 0-7 days 50 mg/kg/dose q8h
>7 days 50 mg/kg/dose q8h
infants and children 100-200 mg/kg/day split q6-8h (max 6 g/day)
meningitis 0-7 days 50 mg/kg/dose q8h
>7 days 50 mg/kg/dose q6h
infants and children 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day)
Ceftriaxone IM/IV usual dose >1 month 50-75 mg/kg q24h (max 2 g/day)
meningitis >1 month 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day)
gonorrhea ≥9 years 250 mg IM once
<9 years 50 mg/kg IM once (max 250 mg)
Ceftazidime IM/IV usual dose 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day)
meningitis or cystic fibrosis 200 mg/kg/day split q6-8h (max 6 g/day)
Cefixime PO usual dose 8 mg/kg/day split q12-24h (max 400 mg/day)

Carbapenems

Drug Indication Age and weight Dose
Meropenem usual dose 20 mg/kg/dose q8h (max 1 g/dose)
meningitis 40 mg/kg/dose q8h (max 2 g/dose)
Ertapenem usual dose 3 months to 12 years 15 mg/kg/dose q12h (max 500 mg/dose)
≥13 years 1 g daily

Glycopeptides

Drug Indication Age and weight Usual dose
Vancomycin IV usual dose 40-60 mg/kg/day split q6-12h (max 2+ g/day)
meningitis or MRSA 60 mg/kg/day split q6-8h (max 4 g/day)
Vancomycin PO Clostridium difficile 10 mg/kg/dose q6h (max 125 mg/dose)